{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SQNS/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T09:02:06.238Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2803,"canonical_name":"SEQUANS COMMUNICATIONS","cik":"0001383395","uei":null,"lei":null,"duns":null,"ticker":"SQNS"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":14},"count":14,"timeline":[{"ts":"2026-09-24","kind":"sec.filing","form_type":"6-K","title":"6-K — SEQUANS COMMUNICATIONS — 2026-09-24","url_slug":"/sec/cik-0001383395/6-k/0001383395-26-000110","accession_number":"0001383395-26-000110","importance":30},{"ts":"2026-09-23","kind":"sec.filing","form_type":"6-K","title":"6-K — SEQUANS COMMUNICATIONS — 2026-09-23","url_slug":"/sec/cik-0001383395/6-k/0001383395-26-000108","accession_number":"0001383395-26-000108","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — SEQUANS COMMUNICATIONS — 2026-08-06","url_slug":"/sec/cik-0001383395/schedule-13g-a/0000315066-26-002144","accession_number":"0000315066-26-002144","importance":30},{"ts":"2026-08-04","kind":"sec.filing","form_type":"6-K","title":"6-K — SEQUANS COMMUNICATIONS — 2026-08-04","url_slug":"/sec/cik-0001383395/6-k/0001383395-26-000103","accession_number":"0001383395-26-000103","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"3","title":"3 — SEQUANS COMMUNICATIONS — 2026-07-01","url_slug":"/sec/cik-0001383395/3/0002115186-26-000004","accession_number":"0002115186-26-000004","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4/A","title":"4/A — SEQUANS COMMUNICATIONS — 2026-07-01","url_slug":"/sec/cik-0001383395/4-a/0002115384-26-000005","accession_number":"0002115384-26-000005","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"6-K","title":"6-K — SEQUANS COMMUNICATIONS — 2026-06-30","url_slug":"/sec/cik-0001383395/6-k/0001383395-26-000100","accession_number":"0001383395-26-000100","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"6-K","title":"6-K — SEQUANS COMMUNICATIONS — 2026-06-02","url_slug":"/sec/cik-0001383395/6-k/0001383395-26-000098","accession_number":"0001383395-26-000098","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"20-F","title":"20-F — SEQUANS COMMUNICATIONS — 2026-05-11","url_slug":"/sec/cik-0001383395/20-f/0001383395-26-000082","accession_number":"0001383395-26-000082","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"4","title":"4 — SEQUANS COMMUNICATIONS — 2026-05-11","url_slug":"/sec/cik-0001383395/4/0001541841-26-000004","accession_number":"0001541841-26-000004","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"4","title":"4 — SEQUANS COMMUNICATIONS — 2026-05-11","url_slug":"/sec/cik-0001383395/4/0002115384-26-000003","accession_number":"0002115384-26-000003","importance":30},{"ts":"2026-05-07","kind":"sec.insider.a","reporter":"Debray Bertrand","title":"Chief of Staff","shares":1970000,"price_per_share":0,"usd_value":0,"security_title":"Ordinary Shares","importance":15},{"ts":"2026-04-28","kind":"sec.insider.a","reporter":"Karam Georges M.","title":"CEO","shares":6000000,"price_per_share":0,"usd_value":0,"security_title":"Ordinary Shares","importance":15},{"ts":"2026-04-28","kind":"sec.insider.a","reporter":"Debray Bertrand","title":"Chief of Staff","shares":2420000,"price_per_share":0,"usd_value":0,"security_title":"Ordinary Shares","importance":15}]}